Ishita Drugs & Industries Ltd - ISHITA DRUGS Share Price

Sector: Pharmaceuticals | ISIN: INE806D01016
₹ 65.75 (1.84%) icon23 May, 2024, 12:00:00 AM

Ishita Drugs & Industries Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 5/23/2024 12:00:00 AM

    ₹ 65.75 1.19 1.84
  • Open
  • ₹ 67.4
  • Prev. Close
  • ₹ 64.56
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 67.45
  • Day's Low
  • ₹ 65.75
  • 52 Week's High
  • ₹ 98.37
  • 52 Week's Low
  • ₹ 50.61
  • Book Value
  • ₹ 31.84
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 19.66
  • P/E
  • 30.44
  • EPS
  • 2.16
  • Divi. Yield
  • 0

Ishita Drugs & Industries Ltd Corporate Actions

02 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Feb , 2024

12:00 AM

31 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Oct , 2023

12:00 AM

28 Aug , 2023

12:00 AM

AGM

Announcement date: 28 Aug , 2023

View Details

03 Aug , 2023

12:00 AM

03 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Aug , 2023

12:00 AM

BookCloser

View Details

No Record Found


Ishita Drugs & Industries Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Ishita Drugs & Industries Ltd SHAREHOLDING SNAPSHOT
24 May , 2024 | 04:29 AM

PROMOTER - TOTAL49.42%

Indian: 49.42%

Foreign: 0%

NON-PROMOTER - TOTAL 50.58%

Institutions: 0.00%

Non-Institutions: 50.58%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Ishita Drugs & Industries Ltd FINANCIALS

View Profit & Loss Graph

Ishita Drugs & Industries Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Ishita Drugs & Industries Ltd

  • Jagdish Agrawal
  • Managing Director
  • Govind Gupta
  • Director
  • Abha Agrawal
  • Non Executive Director
  • Niranjan Agrawal
  • Director
  • Arvind Sapkal
  • Director
  • Srushti Pandya
  • Company Sec. & Compli. Officer

Summary

Ishita Drugs & Industries Limited was incorporated in Feb.92 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient. It has a state-of-art manufacturing facility, in terms of reaction capabilities, quality control and environmental safety. The plant has been designed and constructed to meet GMP norms.The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture, the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in Gujarat, to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not achievable. The Company gradually formed a vertically integrated industry chain covering Drug Intermediates, Active Pharma Ingredients (APIs), excipients and finished dosage forms. The Group has 3 manufacturing facilities located in Gujarat, 2 for APIs and drug intermediates (at Ahmedabad and Surendranagar) and 1 for finished pharmaceutical formulations (at Mehsana).Thereafter, the Company set up a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.95. It established an in-house... Read More


Reports by Ishita Drugs & Industries Ltd


Reports by Ishita Drugs & Industries Ltd

Company FAQ

No Record Found